CSTONE PHARMA-B (02616) announced that preclinical research findings from three of its internally developed drug pipelines have been selected for poster presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The AACR Annual Meeting is one of the most influential academic conferences in the global field of cancer research. The 2026 conference will be held from April 17 to April 22 at the San Diego Convention Center in California, USA. Related research abstracts will be published on April 3, 2026, in the AACR's official journal, *Cancer Research*.